data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Jazz Pharmaceuticals
(NASDAQ:JAZZ)
$158.58
2.57[1.65%]
At close: Jul 1
$158.58
00
After Hours: 4:02PM EDT
Day High/Low153.96 - 159.28
52 Week High/Low117.64 - 186.22
Open / Close155.9 / 158.58
Float / Outstanding54.5M / 62.4M
Vol / Avg.388K / 557.2K
Mkt Cap9.9B
P/E-
50d Avg. Price151.18
Div / Yield-
Payout Ratio-
EPS0.03
Total Float54.5M

Jazz Pharmaceuticals (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals (NASDAQ: JAZZ)

Day High/Low153.96 - 159.28
52 Week High/Low117.64 - 186.22
Open / Close155.9 / 158.58
Float / Outstanding54.5M / 62.4M
Vol / Avg.388K / 557.2K
Mkt Cap9.9B
P/E-
50d Avg. Price151.18
Div / Yield-
Payout Ratio-
EPS0.03
Total Float54.5M
Benzinga - 3 days ago
Benzinga - 4 days ago
Benzinga - 5 days ago
Benzinga - 5 days ago
Benzinga - Jun 23, 2022, 10:59AM
Benzinga - Jun 14, 2022, 5:07AM
Benzinga - Jun 10, 2022, 11:55AM
Benzinga - Jun 9, 2022, 10:46AM
Benzinga - Jun 7, 2022, 7:37AM
Benzinga - Jun 1, 2022, 7:46AM
Benzinga - May 27, 2022, 8:33AM
Benzinga - May 12, 2022, 11:59AM
Benzinga - May 11, 2022, 3:57PM
Benzinga - May 9, 2022, 7:43AM
Benzinga - May 5, 2022, 12:04PM
Benzinga - May 5, 2022, 10:36AM
Benzinga - May 5, 2022, 7:55AM
Benzinga - May 5, 2022, 6:42AM
Benzinga - May 4, 2022, 5:31PM
Benzinga - May 4, 2022, 4:13PM
Benzinga - May 4, 2022, 4:12PM
Benzinga - Apr 24, 2022, 11:31AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small-cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS3.8303.730 -0.1000
REV853.520M813.721M-39.799M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Jazz Pharmaceuticals Questions & Answers

Q
How do I buy Jazz Pharmaceuticals (JAZZ) stock?
A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Jazz Pharmaceuticals's (JAZZ) competitors?
Q
What is the target price for Jazz Pharmaceuticals (JAZZ) stock?
A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by UBS on Tuesday, June 14, 2022. The analyst firm set a price target for 194.00 expecting JAZZ to rise to within 12 months (a possible 22.34% upside). 13 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Jazz Pharmaceuticals (JAZZ)?
A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $158.58 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Jazz Pharmaceuticals (JAZZ) pay a dividend?
A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q
When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?
A

Jazz Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is Jazz Pharmaceuticals (JAZZ) going to split?
A

There is no upcoming split for Jazz Pharmaceuticals.

Q
What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?
A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.